Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
Oncolytic viral (OV) therapies are promising novel treatment modalities for cancers refractory
to conventional treatment, such as glioblastoma, within the central nervous system (CNS) …
to conventional treatment, such as glioblastoma, within the central nervous system (CNS) …
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
JL Zhao, BL Lin, C Luo, Y Yi, P Huang, Y Chen… - Journal of Translational …, 2024 - Springer
Meningeal metastasis (LM) is commonly seen in the advanced stages of cancer patients,
often leading to a rapid decline in survival time and quality of life. Currently, there is still a …
often leading to a rapid decline in survival time and quality of life. Currently, there is still a …
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
Glioblastoma is the most common and lethal central nervous system malignancy with a
median survival after progression of only 6–9 months. Major biochemical mechanisms …
median survival after progression of only 6–9 months. Major biochemical mechanisms …